Scarica l'app Stockscreener
60.90
1.01%
-0.62
Dopo l'orario di chiusura:
60.90
Precedente Chiudi:
$61.52
Aprire:
$63.05
Volume 24 ore:
553.35K
Relative Volume:
0.68
Capitalizzazione di mercato:
$2.61B
Reddito:
$147.17M
Utile/perdita netta:
$-408.35M
Rapporto P/E:
-5.4479
EPS:
-11.1787
Flusso di cassa netto:
$-299.92M
1 W Prestazione:
+1.67%
1M Prestazione:
-1.20%
6M Prestazione:
-37.51%
1 anno Prestazione:
+52.14%
Intervallo 1D:
$57.79
$63.05
Intervallo di 1 settimana:
$56.70
$68.93
Portata 52W:
$29.95
$118.84
Grail Inc Stock (GRAL) Company Profile
Nome
Grail Inc
Settore
Industria
Telefono
(833) 694-2553
Indirizzo
1525 O'BRIEN DRIVE, MENLO PARK
Compare GRAL vs TMO, DHR, IDXX, A, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GRAL
Grail Inc
|
60.90 | 2.64B | 147.17M | -408.35M | -299.92M | -11.18 |
TMO
Thermo Fisher Scientific Inc
|
494.07 | 174.52B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
188.41 | 129.90B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
578.89 | 44.27B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
135.48 | 37.48B | 7.23B | 1.41B | 1.09B | 4.979 |
WAT
Waters Corp
|
371.15 | 35.67B | 3.77B | 449.25M | 240.68M | 7.8556 |
Grail Inc Stock (GRAL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-10 | Iniziato | Mizuho | Neutral |
| 2026-03-18 | Aggiornamento | TD Cowen | Hold → Buy |
| 2026-02-19 | Iniziato | TD Cowen | Hold |
| 2026-02-17 | Iniziato | Robert W. Baird | Outperform |
| 2025-12-02 | Ripresa | Morgan Stanley | Equal-Weight |
| 2025-11-12 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2025-04-21 | Iniziato | Canaccord Genuity | Buy |
| 2024-11-27 | Iniziato | Morgan Stanley | Equal-Weight |
| 2024-11-15 | Iniziato | Wolfe Research | Peer Perform |
| 2024-10-17 | Iniziato | Guggenheim | Neutral |
Mostra tutto
Grail Inc Borsa (GRAL) Ultime notizie
BioTech Co. Hit Investor Suit Over Cancer Test Trial Miss - Law360
GRAL Investors Have Opportunity to Lead GRAIL, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Business Wire
Important Notice to Long-Term Shareholders of Badger Meter, - GlobeNewswire
The Gross Law Firm Reminds GRAIL, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 4, 2026GRAL - Barchart.com
Understanding the Setup: (GRAL) and Scalable Risk - Stock Traders Daily
Press releases provided by CNW - Techaeris
GRAL Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Securities Class Action Lawsuit Against Grail, Inc. - PR Newswire
GRAL Investors Have Opportunity to Lead GRAIL, Inc. Securities Fraud Lawsuit - PR Newswire
HHS indicates skepticism on international cancer risk assessments - Seeking Alpha
Rosen Law Firm Urges GRAIL, Inc. (NASDAQ: GRAL) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - The Joplin Globe
Bronstein, Gewirtz & Grossman LLC Urges GRAIL, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire
GRAL INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Grail, Inc. Investors – Holzer & Holzer, LLC Encourages Investors With Losses to Contact the Firm - Watertown Daily Times
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Grail, ... - Caledonian Record
GRAL INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Grail, Inc. Investors – Holzer ... - Caledonian Record
Robbins LLP reminds investors of GRAIL class action lawsuit - scanx.trade
Why Grail Could Be the Sleeper Stock Everyone's About to Notice - The Globe and Mail
Why Grail Could Be the Sleeper Stock Everyone's About to Notice - The Motley Fool
SHAREHOLDER CLASS ACTION REMINDER: Faruqi & Faruqi, LLP Reminds - GuruFocus
SHAREHOLDER CLASS ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Grail (GRAL) Investors of Securities Class Action Deadline on August 4, 2026 - 巴士的報
Grail, Inc. chief growth officer sells $91,070 in common stock - Investing.com UK
Grail, Inc. chief growth officer sells $91,070 in common stock By Investing.com - Investing.com South Africa
[Form 4] GRAIL, Inc. Insider Trading Activity - Stock Titan
Grail Hit With Shareholder Suit Over Cancer Screening Trial - Bloomberg Law News
Grail investors face August 4, 2026 deadline for securities class action over failed cancer trial results. - Pluang
Grail faces class action lawsuit after failing primary endpoint in cancer detection trial, stock drops 50%. - Pluang
Investor Notice: Robbins LLP Informs Investors of the Grail, Inc. Class Action Lawsuit - The AI Journal
GRAL INVESTOR ALERT: GRAIL, Inc. Investors with Substantial - GlobeNewswire
GRAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Grail - GlobeNewswire
GRAL Initiated Coverage by Goldman Sachs -- Rating Set to Neutra - GuruFocus
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of GRAIL, Inc. Common Stock and Sets a Lead Plaintiff Deadline of August 4, 2026 - GlobeNewswire
Why Is GRAL Stock Down Today? Analysts Lower Targets After UK Trial Setback But Call Selloff Overdone - Stocktwits
Goldman Sachs Initiates Coverage on GRAIL With Neutral Rating, $60 Price Target - Moomoo
Here's Why Grail Stock Soared Higher in May (And Where the Company is Heading Now) - Yahoo Finance
Grail stock initiated at Neutral by Goldman Sachs on FDA uncertainty By Investing.com - Investing.com South Africa
Grail stock initiated at Neutral by Goldman Sachs on FDA uncertainty - Investing.com
GRAL Technical Analysis | Trend, Signals & Chart Patterns | GRAIL INC (NASDAQ:GRAL) - ChartMill
Grail (GRAL) Valuation Check As ASCO 2026 Galleri Data Lifts Early Cancer Detection Story - simplywall.st
GRAIL, Inc. Stock Hits Day Low of $54.83 Amid Price Pressure - Markets Mojo
Grail Stock Surges Over 11 Percent Following Mixed Cancer Test Presentation - asatunews.co.id
Why Grail Stock Popped Today - Yahoo Finance
Grail Stock Plummeted After Galleri Cancer Test NHS Trial Failed - asatunews.co.id
Is Grail Stock a Bad-News Buy After Its Recent Pullback? - Yahoo Finance
Why Grail Shares Are Suddenly Racing Higher - TipRanks
Form 144 GRAIL For: 3 June By Investing.com - Investing.com India
CEO Ofman granted 31K RSUs in GRAIL (NASDAQ: GRAL) equity awards - Stock Titan
GRAL (NASDAQ: GRAL) proposed sale of 2,914 vested RSU shares reported - Stock Titan
GRAIL, Inc. (GRAL) Shareholder/Analyst CallSlideshow (NASDAQ:GRAL) 2026-06-03 - Seeking Alpha
GRAIL's Galleri test cuts stage 4 cancer diagnoses in study despite missed endpoint - MSN
GRAIL (NASDAQ: GRAL) officer reports initial ownership of 165,229 shares - Stock Titan
A Look At GRAIL (GRAL) Valuation After A Sharp One Day Share Price Drop - Yahoo Finance
GRAIL Names Joshua Ofman CEO, Enhances Leadership Compensation - The Globe and Mail
Grail Inc Azioni (GRAL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.71%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):